Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval January 7, 2023
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer’s drug December 30, 2022December 30, 2022
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise December 13, 2022December 13, 2022
Ex-Theranos president Balwani sentenced to nearly 13 years for fraud December 8, 2022December 8, 2022
Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline September 28, 2022September 28, 2022
Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval August 18, 2022August 18, 2022
Japan’s Kowa says ivermectin showed ‘antiviral effect’ against Omicron in research January 31, 2022January 31, 2022